Profound Medical (PROF) Income Statement: Revenue & Earnings

Profound Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Profound Medical Corp. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	10.68	7.20	6.68	6.87	7.30
Cost of Revenue	3.64	2.89	3.66	3.92	3.83
Gross Profit	7.04	4.31	3.02	2.95	3.47
Operating Expenses
Research & Development	16.97	14.42	14.69	15.28	9.91
Selling, General & Administrative	23.13	18.54	17.93	17.97	12.43
Operating Expenses	40.10	32.96	32.62	33.24	22.34
Operating Income	-33.06	-28.65	-29.60	-30.29	-18.86
Other Income/Expense
Interest Income	1.44	1.64	0.80	0.21	0.69
Interest Expense	0.00	0.77	0.17	0.07	-0.54
Other Income/Expense	3.81	-0.58	0.30	0.01	-2.86
Income
Income Before Tax	-27.82	-28.45	-28.38	-30.59	-21.58
Income Tax Expense	0.00	-0.13	0.29	0.11	0.05
Net Income	-27.82	-28.32	-28.67	-30.70	-21.62
Net Income - Continuous Operations	-27.82	-28.32	-28.67	-30.70	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-32.13	-27.72	-26.60	-28.65	-19.50
EBIT	-33.06	-28.65	-28.21	-30.53	-21.03
Depreciation & Amortization	0.94	0.93	1.60	1.88	0.51
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-1.00	-1.00
Diluted EPS	-1.00	-1.00	-1.00	-1.00	-1.00
Basic Shares Outstanding	24.77	21.18	20.77	20.47	17.29
Diluted Shares Outstanding	24.77	21.18	20.77	20.47	17.29